NZ182368A - 1,9-dihydroxy-hexahydrodib-enzipyrans intermediates and pharmaceutical compositions - Google Patents
1,9-dihydroxy-hexahydrodib-enzipyrans intermediates and pharmaceutical compositionsInfo
- Publication number
- NZ182368A NZ182368A NZ182368A NZ18236876A NZ182368A NZ 182368 A NZ182368 A NZ 182368A NZ 182368 A NZ182368 A NZ 182368A NZ 18236876 A NZ18236876 A NZ 18236876A NZ 182368 A NZ182368 A NZ 182368A
- Authority
- NZ
- New Zealand
- Prior art keywords
- hexahydrodib
- enzipyrans
- dihydroxy
- intermediates
- pharmaceutical compositions
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C37/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring
- C07C37/01—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by replacing functional groups bound to a six-membered aromatic ring by hydroxy groups, e.g. by hydrolysis
- C07C37/055—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by replacing functional groups bound to a six-membered aromatic ring by hydroxy groups, e.g. by hydrolysis the substituted group being bound to oxygen, e.g. ether group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/02—Ethers
- C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
- C07C43/205—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring the aromatic ring being a non-condensed ring
- C07C43/2055—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring the aromatic ring being a non-condensed ring containing more than one ether bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/004—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reaction with organometalhalides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
- C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
- C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
- C07D303/22—Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
- C07D311/08—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
- C07D311/16—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted in position 7
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
- C07D311/08—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
- C07D311/18—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted otherwise than in position 3 or 7
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
- C07D311/20—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 hydrogenated in the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/78—Ring systems having three or more relevant rings
- C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Transplantation (AREA)
- Rheumatology (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrane Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Saccharide Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US62821075A | 1975-11-03 | 1975-11-03 |
Publications (1)
Publication Number | Publication Date |
---|---|
NZ182368A true NZ182368A (en) | 1978-04-03 |
Family
ID=24517939
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NZ182368A NZ182368A (en) | 1975-11-03 | 1976-10-19 | 1,9-dihydroxy-hexahydrodib-enzipyrans intermediates and pharmaceutical compositions |
Country Status (25)
Country | Link |
---|---|
JP (3) | JPS5277065A (en) |
AR (1) | AR220521A1 (en) |
BG (3) | BG28058A4 (en) |
CA (1) | CA1099269A (en) |
CH (1) | CH622790A5 (en) |
CS (1) | CS207571B2 (en) |
DD (3) | DD129214A5 (en) |
DK (1) | DK495876A (en) |
EG (1) | EG12648A (en) |
ES (3) | ES452772A1 (en) |
FI (1) | FI763131A (en) |
GR (1) | GR65202B (en) |
HU (1) | HU178321B (en) |
IE (1) | IE43700B1 (en) |
IL (1) | IL50717A (en) |
NO (1) | NO148745C (en) |
NZ (1) | NZ182368A (en) |
PH (3) | PH14811A (en) |
PL (1) | PL125297B1 (en) |
PT (1) | PT65781B (en) |
RO (4) | RO71411A (en) |
SE (1) | SE432251B (en) |
SU (4) | SU843748A3 (en) |
YU (1) | YU268176A (en) |
ZA (1) | ZA766281B (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0765890A (en) * | 1993-08-26 | 1995-03-10 | Sumitomo Wiring Syst Ltd | Connector |
JP2988237B2 (en) * | 1994-01-31 | 1999-12-13 | 住友電装株式会社 | Simple waterproof connector |
JP5037799B2 (en) * | 2005-06-30 | 2012-10-03 | パナソニック株式会社 | TV outlet |
JP7516898B2 (en) | 2020-06-16 | 2024-07-17 | 株式会社アイシン | Shifting device |
-
1976
- 1976-08-19 IE IE1842/76A patent/IE43700B1/en unknown
- 1976-10-11 SE SE7611275A patent/SE432251B/en unknown
- 1976-10-18 GR GR51965A patent/GR65202B/en unknown
- 1976-10-19 IL IL50717A patent/IL50717A/en unknown
- 1976-10-19 NZ NZ182368A patent/NZ182368A/en unknown
- 1976-10-19 CA CA263,717A patent/CA1099269A/en not_active Expired
- 1976-10-21 ZA ZA766281A patent/ZA766281B/en unknown
- 1976-10-22 PH PH19046A patent/PH14811A/en unknown
- 1976-10-27 ES ES452772A patent/ES452772A1/en not_active Expired
- 1976-11-01 YU YU02681/76A patent/YU268176A/en unknown
- 1976-11-01 RO RO7688274A patent/RO71411A/en unknown
- 1976-11-01 DD DD7600195548A patent/DD129214A5/en unknown
- 1976-11-01 DD DD76203283A patent/DD137837A5/en unknown
- 1976-11-01 RO RO7695639A patent/RO75876A/en unknown
- 1976-11-01 RO RO7695637A patent/RO76006A/en unknown
- 1976-11-01 DD DD76213370A patent/DD143774A5/en unknown
- 1976-11-01 RO RO7695638A patent/RO76124A/en unknown
- 1976-11-02 NO NO763725A patent/NO148745C/en unknown
- 1976-11-02 DK DK495876A patent/DK495876A/en not_active Application Discontinuation
- 1976-11-02 CS CS767070A patent/CS207571B2/en unknown
- 1976-11-02 FI FI763131A patent/FI763131A/fi not_active Application Discontinuation
- 1976-11-02 PT PT65781A patent/PT65781B/en unknown
- 1976-11-02 JP JP51132264A patent/JPS5277065A/en active Granted
- 1976-11-02 HU HU76PI550A patent/HU178321B/en unknown
- 1976-11-03 PL PL1976193435A patent/PL125297B1/en not_active IP Right Cessation
- 1976-11-03 BG BG036485A patent/BG28058A4/en unknown
- 1976-11-03 BG BG034599A patent/BG27552A3/en unknown
- 1976-11-03 EG EG680/76A patent/EG12648A/en active
- 1976-11-03 BG BG036486A patent/BG28057A4/en unknown
- 1976-11-03 SU SU762416855A patent/SU843748A3/en active
-
1977
- 1977-07-14 AR AR268433A patent/AR220521A1/en active
- 1977-07-19 PH PH20008A patent/PH14383A/en unknown
- 1977-07-26 SU SU772506503A patent/SU677661A3/en active
- 1977-07-29 SU SU772505754A patent/SU677660A3/en active
- 1977-09-29 ES ES462783A patent/ES462783A1/en not_active Expired
- 1977-09-29 ES ES462784A patent/ES462784A1/en not_active Expired
-
1978
- 1978-02-16 SU SU782579903A patent/SU784772A4/en active
-
1979
- 1979-09-21 CH CH852079A patent/CH622790A5/en not_active IP Right Cessation
- 1979-11-15 JP JP54148293A patent/JPS5943958B2/en not_active Expired
-
1980
- 1980-05-29 PH PH24092A patent/PH16788A/en unknown
- 1980-12-16 JP JP55177955A patent/JPS5943955B2/en not_active Expired
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA7671B (en) | Pharmaceutical composition | |
JPS5272829A (en) | Pharmaceutical composition | |
ZA763917B (en) | Pharmaceutical compositions and compounds | |
IL49424A0 (en) | 1,1,1-triaryl-alkylamines,their preparation and pharmaceutical compositions containing them | |
NZ182555A (en) | Spiro(1,3-dioxalane-4,3)-quinuclidine derivatives and pharmaceutical compositions | |
ZA762748B (en) | Pharmaceutical compositions | |
NZ184394A (en) | N-acyl-l-alanyl -aminoacyl-amides intermediates and pharmaceutical compositions | |
NZ182740A (en) | 7 -acylamido-7 -methoxy-cephalospoims,and prarmaceutical compositions | |
NZ181503A (en) | Substituted diphenyls-ulphides and pharmaceutical compositions | |
NZ182591A (en) | 14-substituted-daunorubicins and pharmaceutical compositions | |
NZ181864A (en) | Noroxymorphones and pharmaceutical compositions | |
NZ182581A (en) | -amino-ketones and pharmaceutical compositions | |
NZ184187A (en) | W-nor-aromatic-13,14-dehydro-prostaglandins pharmaceutical and veterinary compositions intermediates | |
IL49132A (en) | 16,1l-disubstituted androst-4-en-3-ones,their preparation and pharmaceutical compositions containing them | |
PH12557A (en) | Shampoo composition | |
JPS51145511A (en) | Shampoo composition | |
NZ185539A (en) | Cis-4a-aryl-2-substituted-2,3,4,4a,5,6,7,7a-octa hydro-1h-2-pyrindines and pharmaceutical compositions | |
NZ184185A (en) | 3,5,5-trimethylhexanoyl-ferrocene and pharmaceutical compositions | |
NZ182368A (en) | 1,9-dihydroxy-hexahydrodib-enzipyrans intermediates and pharmaceutical compositions | |
IL50554A0 (en) | Novel 2,9-dioxatricyclodecanes their preparation and pharmaceutical compositions containing them | |
ZA761880B (en) | New pharmaceutical compositions | |
IE42772L (en) | Pharmaceutical compositions | |
GB1552416A (en) | Pharmaceutical compositions | |
ZA767215B (en) | Pharmaceutical compositions | |
PH11642A (en) | Benzocycloheptothiophenes and pharmaceutical compositions |